
Browse by Nurse Practitioner Items
Nurse practitioner PBS prescribing
MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS
From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners). Information for nurse practitioners to become authorised PBS prescribers is available from Medicare Australia.
The medicines listed for prescribing by authorised nurse practitioners are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.
PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.
The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health and Ageing regarding medicines for prescribing by authorised nurse practitioners.
Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:
- Continuing therapy only model
Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)
- Shared care model
Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.
Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.
Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.
Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms. For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms. Nurse practitioner PBS prescriptions may include repeats.
Regulation 24 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.
Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from Medicare Australia for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)
State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.
Refine SEARCH
Legend
- MP
- Medical Practitioner
- MW
- Midwife
- NP
- Nurse Practitioner
| Prescriber Code |
Item Code | Name, manner of administration and form & strength | Max Quantity | No. of repeats | Pack size |
|---|---|---|---|---|---|
| MPNP | 1004W | ACETAZOLAMIDE Tablet 250 mg |
100 | 3 | 100 |
| MPNP | 1003T | ACICLOVIR Tablet 200 mg |
50 | 0 | 25 |
| MPNP | 1007B | ACICLOVIR Tablet 200 mg |
90 | 5 | 90 |
| MPNP | 1052J | ACICLOVIR Tablet 800 mg |
35 | 0 | 35 |
| MPNP | 1002R | ACICLOVIR Eye ointment 30 mg per g (3%), 4.5 g |
1 | 0 | 1 |
| MPNP | 1016L | ADRENALINE Injection 1 mg in 1 mL (1 in 1,000) |
5 | 1 | 5 |
| MPNP | 3451P | ADRENALINE Injection 1 mg in 1 mL (1 in 1,000) |
5 | 0 | 5 |
| MPNP | 3408J | ADRENALINE I.M. injection 150 micrograms in 0.3 mL single dose syringe auto-injector |
1 | 0 | 1 |
| MPNP | 3409K | ADRENALINE I.M. injection 300 micrograms in 0.3 mL single dose syringe auto-injector |
1 | 0 | 1 |
| MPNP | 2600W | ALLOPURINOL Tablet 100 mg |
200 | 2 | 100 |
| MPNP | 2604C | ALLOPURINOL Tablet 300 mg |
60 | 2 | 60 |
| MPNP | 2130D | ALPRAZOLAM Tablet 250 micrograms |
50 | 0 | 50 |
| MPNP | 2131E | ALPRAZOLAM Tablet 500 micrograms |
50 | 0 | 50 |
| MPNP | 2132F | ALPRAZOLAM Tablet 1 mg |
50 | 2 | 50 |
| MPNP | 2157M | ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE Oral suspension 200 mg-200 mg per 5 mL, 500 mL |
2 | 5 | 1 |
| MPNP | 2159P | ALUMINIUM HYDROXIDE with MAGNESIUM TRISILICATE and MAGNESIUM HYDROXIDE Oral suspension 250 mg-120 mg-120 mg per 5 mL, 500 mL |
2 | 5 | 1 |
| MPNP | 3016R | AMANTADINE HYDROCHLORIDE Capsule 100 mg |
100 | 5 | 100 |
| MPNP | 3417W | AMINO ACID FORMULA with FAT, CARBOHYDRATE, VITAMINS, MINERALS, and TRACE ELEMENTS, without METHIONINE and supplemented with
DOCOSAHEXANOIC ACID Oral liquid 125 mL, 36 |
4 | 5 | 1 |
| MPNP | 2650L | AMINO ACID FORMULA with VITAMINS and MINERALS without LYSINE and low in TRYPTOPHAN Infant formula, powder 400 g |
8 | 5 | 1 |
| MPNP | 2646G | AMINO ACID FORMULA with VITAMINS and MINERALS without LYSINE and low in TRYPTOPHAN Powder 500 g |
8 | 5 | 1 |
| MPNP | 3443F | AMINO ACID FORMULA with VITAMINS and MINERALS without METHIONINE, THREONINE and VALINE and low in ISOLEUCINE Sachets 25 g, 30 |
4 | 5 | 1 |
| MPNP | 3444G | AMINO ACID FORMULA with VITAMINS and MINERALS without METHIONINE, THREONINE and VALINE and low in ISOLEUCINE Sachets 24 g, 30 |
4 | 5 | 1 |
| MPNP | 1411G | AMINO ACID FORMULA with VITAMINS and MINERALS without PHENYLALANINE Sachets 18.2 g, 60 |
3 | 5 | 1 |
| MPNP | 2738D | AMINO ACID FORMULA with VITAMINS and MINERALS without PHENYLALANINE Powder 500 g |
8 | 5 | 1 |
| MPNP | 2739E | AMINO ACID FORMULA with VITAMINS and MINERALS without PHENYLALANINE Powder 500 g |
8 | 5 | 1 |
| MPNP | 2382J | AMINO ACID FORMULA with VITAMINS and MINERALS without PHENYLALANINE Oral liquid 87 mL, 30 |
4 | 5 | 1 |
| MPNP | 2474F | AMINO ACID FORMULA with VITAMINS and MINERALS without PHENYLALANINE Oral liquid 174 mL, 30 |
4 | 5 | 1 |
| MPNP | 3078B | AMINO ACID FORMULA with VITAMINS and MINERALS without PHENYLALANINE and TYROSINE Powder 500 g |
8 | 5 | 1 |
| MPNP | 2380G | AMINO ACID FORMULA with VITAMINS and MINERALS without VALINE, LEUCINE and ISOLEUCINE Infant formula, powder 400 g |
8 | 5 | 1 |
| MPNP | 2375B | AMINO ACID FORMULA with VITAMINS and MINERALS without VALINE, LEUCINE and ISOLEUCINE Oral liquid 130 mL, 30 |
4 | 5 | 1 |
| MPNP | 2347M | AMINO ACID FORMULA without PHENYLALANINE Sachets containing powder 20 g, 30 |
7 | 5 | 1 |
| MPNP | 2246F | AMINO ACID SYNTHETIC FORMULA supplemented with LONG CHAIN POLYUNSATURATED FATTY ACIDS Compound powder 400 g |
8 | 5 | 1 |
| MPNP | 2560R | AMINO ACID SYNTHETIC FORMULA supplemented with LONG CHAIN POLYUNSATURATED FATTY ACIDS Compound powder 400 g |
8 | 5 | 1 |
| MPNP | 2250K | AMINO ACIDS—SYNTHETIC, FORMULA Compound powder 400 g |
12 | 5 | 1 |
| MPNP | 2244D | AMINO ACIDS—SYNTHETIC, FORMULA Compound powder 400 g |
8 | 5 | 1 |
| MPNP | 3066J | AMINO ACIDS—SYNTHETIC, FORMULA Compound powder 400 g |
8 | 5 | 1 |
| MPNP | 2553J | AMINO ACIDS—SYNTHETIC, FORMULA Compound powder 400 g |
8 | 5 | 1 |
| MPNP | 2344J | AMIODARONE Tablet containing amiodarone hydrochloride 100 mg |
30 | 5 | 30 |
| MPNP | 2343H | AMIODARONE Tablet containing amiodarone hydrochloride 200 mg |
30 | 5 | 30 |
| MPNP | 2417F | AMITRIPTYLINE HYDROCHLORIDE Tablet 10 mg |
50 | 2 | 50 |
| MPNP | 2418G | AMITRIPTYLINE HYDROCHLORIDE Tablet 25 mg |
50 | 2 | 50 |
| MPNP | 2429W | AMITRIPTYLINE HYDROCHLORIDE Tablet 50 mg |
50 | 2 | 50 |
| MPNP | 2751T | AMLODIPINE Tablet 5 mg (as besylate) |
30 | 5 | 30 |
| MPNP | 1343Q | AMLODIPINE Tablet 5 mg (as maleate) |
30 | 5 | 30 |
| MPNP | 2752W | AMLODIPINE Tablet 10 mg (as besylate) |
30 | 5 | 30 |
| MPNP | 1345T | AMLODIPINE Tablet 10 mg (as maleate) |
30 | 5 | 30 |
| MPMWNP | 1884E | AMOXYCILLIN Capsule 250 mg |
20 | 1 | 20 |
| MPMWNP | 1889K | AMOXYCILLIN Capsule 500 mg |
20 | 1 | 20 |
| MPNP | 1878W | AMOXYCILLIN Sachet containing oral powder 3 g |
1 | 0 | 1 |
| MPNP | 1888J | AMOXYCILLIN Powder for paediatric oral drops 100 mg per mL, 20 mL |
1 | 1 | 1 |
| MPNP | 1886G | AMOXYCILLIN Powder for syrup 125 mg per 5 mL, 100 mL |
1 | 1 | 1 |
| MPNP | 1887H | AMOXYCILLIN Powder for syrup 250 mg per 5 mL, 100 mL |
1 | 1 | 1 |
| MPMWNP | 1891M | AMOXYCILLIN with CLAVULANIC ACID Tablet 500 mg-125 mg |
10 | 1 | 10 |
| MPNP | 1892N | AMOXYCILLIN with CLAVULANIC ACID Powder for syrup 125 mg-31.25 mg per 5 mL, 75 mL |
1 | 1 | 1 |
| MPNP | 2931G | AMPHOTERICIN Lozenge 10 mg |
20 | 1 | 20 |
| MPNP | 2390T | AMPICILLIN Powder for injection 500 mg |
5 | 1 | 5 |
| MPNP | 2977Q | AMPICILLIN Powder for injection 1 g |
5 | 1 | 5 |
| MPNP | 5054B | APIXABAN Tablet 2.5 mg |
30 | 0 | 30 |
| MPNP | 5061J | APIXABAN Tablet 2.5 mg |
60 | 0 | 60 |
| MPNP | 5140M | ASENAPINE Sublingual wafer 5 mg (as maleate) |
60 | 5 | 60 |
| MPNP | 5141N | ASENAPINE Sublingual wafer 10 mg (as maleate) |
60 | 5 | 60 |
| MPNP | 1010E | ASPIRIN Tablet 300 mg (dispersible) |
96 | 1 | 96 |
| MPNP | 1081X | ATENOLOL Tablet 50 mg |
30 | 5 | 30 |
| MPNP | 1089H | ATROPINE Injection containing atropine sulfate 600 micrograms in 1 mL |
10 | 1 | 10 |
| MPNP | 3453R | ATROPINE Injection containing atropine sulfate 600 micrograms in 1 mL |
10 | 0 | 10 |
| MPNP | 1093M | ATROPINE Eye drops containing atropine sulfate 10 mg per mL (1%), 15 mL |
1 | 2 | 1 |
| MPNP | 1095P | AURANOFIN Tablet 3 mg |
60 | 5 | 60 |
| MPNP | 2688L | AZATHIOPRINE Tablet 25 mg |
100 | 2 | 100 |
| MPNP | 2687K | AZATHIOPRINE Tablet 50 mg |
100 | 2 | 100 |